Agentschap NL
3
6M
3
1
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Agentschap NL, startups are often financed by Wellington Partners, Sanquin Blood Supply Foundation, OostNL. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, Michael J. Fox Foundation. In the next rounds fund is usually obtained by RA Capital Management, Medicxi Ventures, Janke Dittmer.
The top amount of exits for fund were in 2014. The real fund results show that this Corporate Investor is 47 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2011. This Agentschap NL works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Life Science. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ORCA Therapeutics, Xenikos, Sapiens Steering Brain Stimulation.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Therapeutics (2)
- Health Care (2)
- Life Science (2)
- Biotechnology (2)
- Simulation (1) Show 2 more
- Investments by region
-
- Germany (1)
- Netherlands (2)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 66M
- Group Appearance index
- 0.33
- Avg. company exit year
- 3
- Avg. multiplicator
- 3.39
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Sapiens Steering Brain Stimulation | 28 Nov 2011 | Health Care, Medical, Therapeutics, Simulation | Early Stage Venture | 11M | Munich, Bavaria, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.